Ocean Biomedical, Inc.
OCEA· OTC
OCEAOcean Biomedical, Inc.
Filed Dec 23, 2024 · 10-Q · 176 days after period end · 0001493152-24-051208
| Metric | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|
| Net Income | -$17.23M | -$11.43M | -$184.93K |
| EPS Diluted | -$0.63 | -$0.43 | -$0.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ocean Biomedical, Inc. · CIK 1869974 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Dec 23, 2024 · 176 d after period end
